Table 2.

Prospective trials on transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis

Group	No. of patients	Treatments	Child-Pugh A	Survival
Luo et al[81]	164 (84 vs 80)	TACE vs Control	Not known	1-yr survival 30.9% vs 9.2%
Niu et al[82]	150 (115 vs 35)	TACE vs Control	88 vs 21	Median survival 8.67 mo vs 14 mo
Kim et al[83]	110 (49 vs 61)	TACE vs TACI	30 vs 22	Median survival 14.9 mo vs 4.4 mo
Peng et al[25]	603 (402 vs 201)	TACE vs Resection	389 vs 197	Median survival 42 mo vs 14.1 mo

TACE: Transarterial chemoembolization; PVTT: Portal vein tumor thrombosis; TACI: Transcatheter arterial chemoinfusion.